1.Fecal Microbiota Transplantation and the Brain Microbiota in Neurological Diseases.
Clinical Endoscopy 2016;49(6):579-579
No abstract available.
Brain*
;
Fecal Microbiota Transplantation*
;
Microbiota*
2.Clinical Usefulness of Fecal Microbiota Transplantation.
Journal of Neurogastroenterology and Motility 2017;23(2):149-150
No abstract available.
Fecal Microbiota Transplantation*
3.Is Expansion of Fecal Microbiota Transplantation Available?.
The Korean Journal of Gastroenterology 2017;70(4):211-213
No abstract available.
Fecal Microbiota Transplantation*
4.Fecal Microbiota Transplantation as a Treatment of Recurrent Clostridium difficile Infection: Where Are We Now and Where Are We Heading?.
The Korean Journal of Gastroenterology 2017;69(4):203-205
No abstract available.
Clostridium difficile*
;
Clostridium*
;
Fecal Microbiota Transplantation*
;
Head*
6.Chinese expert consensus on screening and management of fecal microbiota transplantation donors (2022 edition).
Chinese Journal of Gastrointestinal Surgery 2022;25(9):757-765
Fecal microbiota transplantation (FMT) has been recommended by clinical practical guidelines and consensus for the treatment of a variety of intestinal diseases, but in more and more medical institutions trying to develop this technology in clinical practice, how to screen and manage donors has become an urgent need for regulation. In view of this, based on evidence-based medical evidence, Society of Parenteral and Enteral Nutrition of Chinese Medical Association and Microecology Professional Committee of Shanghai Preventive Medicine Association jointly formulate an expert consensus on the screening and management of donors, including screening on the internet and in clinic, evaluation and selection during donation, establishment of the standard of donor management, the follow-up system and the professional support system, with a view to improving the quality of microbiota transplantation donors, reducing adverse events, and promoting the standardized clinical application of FMT.
China
;
Consensus
;
Fecal Microbiota Transplantation
;
Feces
;
Humans
;
Microbiota
8.Chinese experts consensus on clinical practice of the selection and establishment of fecal microbiota transplantation delivery routes.
Chinese Journal of Gastrointestinal Surgery 2020;23(Z1):14-20
Fecal microbiota transplantation (FMT) has gradually shown application prospects in the treatment of intestinal and extraintestinal diseases. In order to standardized FMT operation, based on the clinical experience of the Tenth People's Hospital Affiliated to Tongji University, combined with domestic and foreign literature, Parenteral and Enteral Nutrition Branch of Chinese Medical Association, Enhanced Recovery after Surgery Branch of China International Health Care Promotion Exchange Association, China Microecological Treatment Innovation Alliance, and Microecology Committee of Shanghai Preventive Medicine Association to formulated the" Chinese experts consensus on clinical practice of the selection and establishment of fecal microbiota transplantation delivery routes". It includes four parts: the selection of delivery route, the methodology of transplantation path establishment, the clinical application, and the monitoring of adverse events.
China
;
Consensus
;
Fecal Microbiota Transplantation
;
adverse effects
;
methods
;
standards
;
Humans
9.Application of metagenomic and culturomic technologies in fecal microbiota transplantation: a review.
Yingjiao JU ; Xiaotong WANG ; Yinyu WANG ; Cuidan LI ; Liya YUE ; Fei CHEN
Chinese Journal of Biotechnology 2022;38(10):3594-3605
Fecal microbiota transplantation (FMT) refers to using the intestinal microorganisms present in the feces or processed feces from healthy people for treating various types of diseases, such as digestive and metabolic diseases. The rapid development of metagenomic and culturomic technologies in gut microbiome analysis provides powerful tools for the FMT research and its clinical applications. Metagenomics technologies comprehensively revealed the diversity and functions of gut microbiota under health and disease conditions, while culturomics technologies helped isolation and identification of "unculturable" bacteria in the human gut under conventional culture conditions. The combination of these two technologies not only enabled us better understand the FMT regularities of cause and effect in clinical practices, but also effectively promoted its applications. Considering the above advantages, this article summarized the applications of metagenomics and culturomics technologies in FMT and prospected its future development trend.
Humans
;
Fecal Microbiota Transplantation
;
Metagenomics
;
Feces/microbiology*
;
Gastrointestinal Microbiome
;
Bacteria
10.Further improve the standardization construction and development level of fecal microbiota transplantation (FMT) in China.
Huan Long QIN ; Qi Yi CHEN ; Ning LI
Chinese Journal of Gastrointestinal Surgery 2022;25(9):766-770
In the past ten years, the clinical application of fecal microbiota transplantation (FMT) in the treatment of intestinal and extraintestinal diseases has attracted much attention. In China, there are more than 300 hospitals that have developed FMT, but the development of FMT is still in its early stage. The clinical practice of FMT needs to form a standardized system, including management of donors and acceptors, preparation of capsules containing certain gut bacteria, evaluation of effectiveness, and study of fecal microbiota and disease. In order to promote the establishment of the standard system of FMT and the healthy development of FMT, this paper expounds the establishment of the standardization of domestic flora transplantation according to the relevant literature, as well as the experience of 10000 cases and 95300 times of FMT in our center.
Capsules
;
China
;
Fecal Microbiota Transplantation
;
Feces/microbiology*
;
Humans
;
Reference Standards